| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
18,124 |
14,962 |
$1.16M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,669 |
3,473 |
$345K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,328 |
2,275 |
$251K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,829 |
1,786 |
$210K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,726 |
1,691 |
$172K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,194 |
1,173 |
$120K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
5,697 |
5,493 |
$90K |
| 87428 |
|
628 |
601 |
$31K |
| 99243 |
|
316 |
308 |
$29K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,593 |
1,417 |
$24K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,232 |
2,004 |
$21K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
187 |
171 |
$20K |
| 90686 |
|
2,295 |
2,245 |
$11K |
| 99460 |
|
71 |
53 |
$8K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
209 |
202 |
$7K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
255 |
240 |
$6K |
| 90670 |
|
1,338 |
1,314 |
$5K |
| 83655 |
|
410 |
400 |
$2K |
| 90633 |
|
949 |
927 |
$2K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
82 |
79 |
$1K |
| 87807 |
|
166 |
164 |
$1K |
| 90671 |
|
73 |
71 |
$912.38 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
99 |
93 |
$592.36 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
81 |
79 |
$513.02 |
| 99462 |
|
106 |
64 |
$462.36 |
| 99188 |
|
56 |
53 |
$427.50 |
| 85018 |
|
408 |
400 |
$407.16 |
| 90696 |
|
25 |
25 |
$380.52 |
| 90651 |
|
240 |
234 |
$269.00 |
| 90648 |
|
352 |
345 |
$208.00 |
| 81002 |
|
90 |
81 |
$163.98 |
| 90621 |
|
36 |
36 |
$52.00 |
| 90680 |
|
793 |
777 |
$33.00 |
| 90698 |
|
245 |
242 |
$32.00 |
| 90707 |
|
54 |
54 |
$24.01 |
| 99173 |
|
4,586 |
3,923 |
$0.00 |
| 90710 |
|
27 |
27 |
$0.00 |
| 90734 |
|
99 |
98 |
$0.00 |
| 99401 |
|
1,260 |
1,237 |
$0.00 |
| 90715 |
|
25 |
25 |
$0.00 |
| 36416 |
|
461 |
420 |
$0.00 |
| 90723 |
|
335 |
329 |
$0.00 |
| 92551 |
|
4,509 |
3,865 |
$0.00 |
| 90716 |
|
53 |
53 |
$0.00 |
| 90697 |
|
521 |
366 |
$0.00 |
| 90619 |
|
46 |
42 |
$0.00 |
| 90677 |
|
95 |
92 |
$0.00 |
| 96127 |
|
14 |
12 |
$0.00 |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
28 |
24 |
$0.00 |